Table 4. Association between different genotypes and the success of flecainide-induced cardioversion.

	Flecainide Success	OR	95% CI	p
Arg389Arg (n = 36)	20 (55.5%)	3.30	1.34−8.13	0.003
Ser49Ser (n = 32)	17 (53.1%)	2.53	1.03−6.23	0.04
Ser49Gly (n = 4)	3 (75.0%)	5.03	0.50−50.52	0.14
Gly49Gly (n = 0)	-	-	-	-
Arg389Gly (n = 44)	13 (29.5%)	0.44	0.18−1.06	0.066
Ser49Ser (n = 20)	8 (40.0%)	1.05	0.38−2.92	0.93
Ser49Gly (n = 24)	5 (20.8%)	0.31	0.10−0.93	0.03
Gly49Gly (n = 0)	-	-	-	-
Gly389Gly (n = 7)	1 (14.3%)	0.24	0.03−2.07	0.17
Ser49Ser (n = 7)	1 (14.3%)	0.24	0.03−2.07	0.17
Ser49Gly (n = 0)	-	-	-	-
Gly49Gly (n = 0)	-	-	-	-